Table 2.
Biological outcome measure | Number of samples per session | Sampling time points per session | Sampling procedure |
---|---|---|---|
Autonomic nervous system | |||
sAA | 7 | Baseline, − 1, + 1, + 10, + 20, + 30, + 45 min | Saliva sample |
HR | - | Continuously | ECG |
HRV | - | Continuously | ECG |
HPA axis | |||
Cortisol | 7 | Baseline, − 1, + 1, + 10, + 20, + 30, + 45 min | Saliva sample |
Inflammatory system | |||
IL-6 | 3 | − 1, + 30, + 90 min | Peripheral blood sample |
IL-6 expression | 3 | − 1, + 30, + 90 min | Peripheral blood sample |
IL-1β expression | 3 | − 1, + 30, + 90 min | Peripheral blood sample |
NF-кB expression | 3 | − 1, + 30, + 90 min | Peripheral blood sample |
IкB expression | 3 | − 1, + 30, + 90 min | Peripheral blood sample |
ECG electrocardiogram, HPA axis hypothalamus-pituitary adrenal axis, HR heart rate, HRV heart rate variability, IкB I kappa B kinase, IL Interleukin, NF-кB nuclear Factor kappa B, sAA salivary alpha-amylase